Profile data is unavailable for this security.
About the company
Tarsons Products Limited is an India-based labware company. The Company is engaged in designing, development, manufacturing and marketing of consumables, reusables and others including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies contract research organizations (CROs), diagnostic companies and hospitals. The Company is also engaged in the manufacturing of range a of labware products which helps scientific discovery and improve healthcare. The Company has developed a diverse range of labware products under the categories: consumables, reusables and others. The Company's consumables products include pipette tips, centrifuge ware, petri dishes, cryo ware and storage vials. Its reusable products include bottles and carboys, beakers, cylinders and racks. Its other products include centrifuge, vortex, and pipettors.
- Revenue in INR (TTM)2.96bn
- Net income in INR426.40m
- Incorporated2021
- Employees713.00
- LocationTarsons Products Ltd902 Martin Burn Business ParkBP-3,Saltlake,Sector-VKOLKATA 700091IndiaIND
- Phone+91 3 335220300
- Fax+91 3 322892956
- Websitehttps://www.tarsons.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beijing Succeeder Technology Inc | 3.29bn | 1.39bn | 25.80bn | 296.00 | 18.50 | 1.37 | -- | 7.85 | 1.14 | 1.14 | 2.68 | 15.36 | 0.1711 | 2.39 | 9.52 | 961,290.60 | 7.26 | 7.77 | 7.63 | 8.25 | 62.48 | 61.03 | 42.43 | 38.34 | 14.58 | -- | 0.00007 | 22.22 | 20.40 | 6.60 | 12.29 | 15.57 | 99.03 | -- |
| Venus MedTech HangZhou Inc | 5.69bn | -8.15bn | 26.58bn | 865.00 | -- | 0.7861 | -- | 4.67 | -1.74 | -1.74 | 1.21 | 7.15 | 0.1014 | 0.9402 | 1.65 | 613,264.20 | -15.04 | -13.20 | -17.41 | -14.97 | 79.21 | 79.51 | -148.37 | -152.83 | 1.86 | -8.78 | 0.2206 | -- | 20.89 | 33.62 | 33.46 | -- | 58.20 | -- |
| Nanjing Vishee Medical Technology Co Ltd | 5.25bn | 1.48bn | 26.98bn | 700.00 | 18.22 | 1.41 | -- | 5.14 | 1.34 | 1.34 | 4.76 | 17.29 | 0.2583 | 3.38 | 15.91 | 649,077.10 | 7.27 | 10.27 | 7.85 | 11.43 | 70.28 | 73.26 | 28.16 | 33.99 | 10.18 | -- | 0.00 | 47.57 | 43.72 | 17.34 | 45.22 | 16.55 | 26.69 | -- |
| Beijing Hotgen Biotech Co Ltd | 5.25bn | -305.39m | 26.98bn | 1.04k | -- | 0.6895 | -- | 5.14 | -0.3093 | -0.3093 | 5.14 | 36.65 | 0.1264 | 1.64 | 6.32 | 438,645.70 | -1.04 | 29.65 | -1.11 | 34.70 | 50.71 | 56.08 | -8.25 | 32.26 | 5.50 | -- | 0.0027 | 41.92 | -84.78 | 23.67 | -97.10 | -10.67 | 57.98 | -- |
| Tarsons Products Ltd | 2.96bn | 426.40m | 27.53bn | 713.00 | 64.51 | 4.49 | 33.15 | 9.29 | 8.02 | 8.02 | 55.74 | 115.19 | 0.3491 | 0.6763 | 4.13 | -- | 5.02 | -- | 6.00 | -- | 72.26 | -- | 14.39 | -- | 0.4999 | 5.87 | 0.305 | -- | 4.64 | -- | -47.17 | -- | -- | -- |
| Chemclin Diagnostics Co Ltd | 5.26bn | 1.74bn | 27.56bn | 731.00 | 15.81 | 1.73 | -- | 5.24 | 0.3764 | 0.3764 | 1.14 | 3.45 | 0.2684 | 1.02 | 17.03 | 623,526.50 | 8.89 | 11.01 | 9.82 | 12.32 | 74.73 | 74.19 | 33.11 | 31.07 | 5.09 | -- | 0.1518 | 36.64 | -4.28 | 4.00 | -3.44 | -- | 44.10 | -- |
| Jinan High-tech Development Co Ltd | 6.41bn | -1.38bn | 27.58bn | 716.00 | -- | 12.27 | -- | 4.30 | -0.1353 | -0.1353 | 0.6275 | 0.2201 | 0.1874 | 0.6198 | 0.6935 | 775,274.40 | -4.46 | -2.99 | -22.92 | -9.42 | 15.19 | 30.52 | -23.79 | -10.84 | 0.5687 | -- | 0.4146 | -- | -58.29 | -13.80 | -618.17 | -- | -35.45 | -- |
| CI Medical Co Ltd | 25.37bn | 984.78m | 27.72bn | 473.00 | 28.15 | 2.54 | 15.43 | 1.09 | 36.16 | 36.16 | 931.59 | 401.25 | 1.28 | 4.14 | 13.80 | 98,467,230.00 | 5.05 | 10.83 | 9.27 | 15.65 | 26.14 | 27.73 | 3.94 | 6.06 | 0.4352 | -- | 0.4604 | 12.83 | 6.38 | 12.07 | -17.41 | 9.38 | 77.24 | 13.65 |
| Alpha IVF Group Bhd | 3.01bn | 951.61m | 27.96bn | 96.00 | 29.38 | 8.30 | 25.76 | 9.28 | 0.0109 | 0.0109 | 0.0345 | 0.0386 | -- | -- | -- | -- | -- | -- | -- | -- | 58.10 | -- | 32.26 | -- | 6.65 | 89.80 | 0.0781 | -- | 21.90 | -- | -0.5815 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| First Sentier Investors (Singapore)as of 31 Mar 2024 | 3.00m | 5.65% |
| First Sentier Investors (UK) IM Ltd.as of 30 Jun 2024 | 867.75k | 1.63% |
| Mellon Investments Corp.as of 03 Jul 2024 | 95.26k | 0.18% |
| SSgA Funds Management, Inc.as of 03 Jul 2024 | 61.26k | 0.12% |
| Motilal Oswal Asset Management Co. Ltd.as of 30 Jun 2024 | 26.93k | 0.05% |
| Groww Asset Management Ltd.as of 30 Jun 2024 | 141.00 | 0.00% |
| Royce & Associates LPas of 30 Jun 2024 | 0.00 | 0.00% |
| Macquarie Funds Management Hong Kong Ltd.as of 30 Sep 2022 | 0.00 | 0.00% |
| PineBridge Investments Asia Ltd.as of 30 Jun 2023 | 0.00 | 0.00% |
